Results 1 to 10 of about 187,404 (263)

Identification and validation of a hypoxia- and immune-related prognostic signature for pancreatic cancer [PDF]

open access: yesBiochemistry and Biophysics Reports
Pancreatic cancer is a lethal disease with a poor prognosis. Immunity and hypoxia are critical characteristics of the tumor microenvironment and are closely associated with cancer prognosis. The present study aimed to identify a novel hypoxia- and immune-
Ganghua Yang   +7 more
doaj   +2 more sources

Identification of a Novel Glycosyltransferase Prognostic Signature in Hepatocellular Carcinoma Based on LASSO Algorithm

open access: yesFrontiers in Genetics, 2022
Although many prognostic models have been developed to help determine personalized prognoses and treatments, the predictive efficiency of these prognostic models in hepatocellular carcinoma (HCC), which is a highly heterogeneous malignancy, is less than ...
Zhiyang Zhou   +5 more
doaj   +1 more source

Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer

open access: yesFrontiers in Genetics, 2021
Costimulatory molecules have been proven to enhance antitumor immune responses, but their roles in prostate cancer (PCa) remain unexplored. In this study, we aimed to explore the gene expression profiles of costimulatory molecule genes in PCa and ...
Shengdong Ge   +21 more
doaj   +1 more source

Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer

open access: yesHuman Genomics, 2021
Highlights 1. We first comprehensive investigated the expression, protein–protein interaction, and prognostic value of unfolded protein response-related gene in bladder cancer. 2.
Ke Zhu   +4 more
doaj   +1 more source

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma

open access: yesFrontiers in Genetics, 2020
Hepatocellular carcinoma (HCC) is one of the most prevalent life-threatening human cancers and the leading cause of cancer-related mortality, with increased global incidence within the last decade.
Ran Li   +4 more
doaj   +1 more source

Integrative Analysis Constructs an Extracellular Matrix-Associated Gene Signature for the Prediction of Survival and Tumor Immunity in Lung Adenocarcinoma

open access: yesFrontiers in Cell and Developmental Biology, 2022
Background: Lung adenocarcinoma (LUAD) accounts for the majority of lung cancers, and the survival of patients with advanced LUAD is poor. The extracellular matrix (ECM) is a fundamental component of the tumor microenvironment (TME) that determines the ...
Lingyan Xiao   +6 more
doaj   +1 more source

A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)

open access: yesCancer Cell International, 2021
Background Lung adenocarcinoma (LUAD) is one of the most common types in the world with a high mortality rate. Despite advances in treatment strategies, the overall survival (OS) remains short.
Aisha Al-Dherasi   +21 more
doaj   +1 more source

A novel pyroptosis-related prognostic signature for lung adenocarcinoma: Identification and multi-angle verification

open access: yesFrontiers in Genetics, 2023
Background: Lung adenocarcinoma (LUAD) is an aggressive disease of heterogeneous characteristics with poor prognosis and high mortality. Pyroptosis, a newly uncovered type of programmed cell death with an inflammatory nature, has been determined to hold ...
Xinyue Wang   +20 more
doaj   +1 more source

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma [PDF]

open access: yes, 2015
Accurate assessment of neuroblastoma outcome prediction remains challenging. Therefore, this study aims at establishing novel prognostic tumor DNA methylation biomarkers.
  +24 more
core   +5 more sources

Development of a novel glycolysis-related genes signature for isocitrate dehydrogenase 1-associated glioblastoma multiforme

open access: yesFrontiers in Immunology, 2022
BackgroundThe significant difference in prognosis between IDH1 wild-type and IDH1 mutant glioblastoma multiforme (GBM) may be attributed to their metabolic discrepancies. Hence, we try to construct a prognostic signature based on glycolysis-related genes
Xiaomin Cai   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy